Senseonics Holdings Inc. (SENS)

3.72 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

NYSE American : Healthcare

Prev Close 3.72

Price Open 3.74

Volume: 231

Avg Volume: 1.92M

Market Cap: 654.82M

P/E Ratio -6.53

52 Wk Range 2.35-5.29



SENS Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
174.28M
13.37M
5.89
7.67%

2018-07-13
173.74M
13.25M
3.16
7.63%

2018-06-29
135.67M
12.14M
3.54
8.95%

2018-06-15
135.67M
8.03M
6.84
5.92%




SENS Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-08
Q2 2018
AMC
-0.13 (2)
0.00
0.00

2018-05-10
Q1 2018
AMC
-0.11 (2)
-0.16
-0.05

2018-05-03
Q1 2018
N/A
-0.11 (2)
0.00
0.00

2018-03-13
Q4 2017
AMC
-0.14 (2)
-0.12
0.02

News

Senseonics Holdings Inc. (SENS) CEO Tim Goodnow on Q2 2018 Results - Earnings Call Transcript (2018-08-08 22:46 SeekingAlpha)

Senseonics Holdings Inc., (NYSEMKT:SENS) Q2 2018 Earnings Conference Call August 8, 2018 4:30 PM ET Executives Tim Goodnow - President and Chief Executive Officer Don Elsey - Chief Financial Officer Mike Gill - Vice President and General Manager, U.S. Region Mirasol Panlilio …

 


Statistics

Shares Outstanding: 176.03M

Top 15 Institution Percent: 61.40

Price To Sales: 56.27

Price To Book: 6.16

Revenue: 2.10M

Gross Profit: -860000

Cash: 52.70M

Debt: 24.30M

Return On Assets: -69.13

Return On Equity: -150.20

Profit Margin: N/A

Price History

Beta: -0.17

50-day Moving Avg: 4.08

200-day Moving Avg: 3.25

YTD Change: 37.78

5-day Change: -8.82

1-month Change: -7.00

3-month Change: 16.61

6-month Change: 41.44

1-year Change: 53.72

Revenue Per Share: 0.00

Revenue Per Employee: 22309.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Senseonics Holdings Inc.

Exchange: NYSE American

Industry: Medical Diagnostics & Research

Sector: Healthcare

Website: http://www.senseonics.com

Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients.